ATE551997T1 - Sulfonamid-derivate zur behandlung von diabetes - Google Patents

Sulfonamid-derivate zur behandlung von diabetes

Info

Publication number
ATE551997T1
ATE551997T1 AT04787131T AT04787131T ATE551997T1 AT E551997 T1 ATE551997 T1 AT E551997T1 AT 04787131 T AT04787131 T AT 04787131T AT 04787131 T AT04787131 T AT 04787131T AT E551997 T1 ATE551997 T1 AT E551997T1
Authority
AT
Austria
Prior art keywords
group
sulfonamide
treatment
hydrogen
nitrogen atom
Prior art date
Application number
AT04787131T
Other languages
English (en)
Inventor
Thomas Rueckle
Pierre-Alain Vitte
Jean-Pierre Gotteland
Original Assignee
Merck Serono Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Serono Sa filed Critical Merck Serono Sa
Application granted granted Critical
Publication of ATE551997T1 publication Critical patent/ATE551997T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT04787131T 2003-09-12 2004-09-13 Sulfonamid-derivate zur behandlung von diabetes ATE551997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03102742 2003-09-12
PCT/EP2004/052143 WO2005025558A1 (en) 2003-09-12 2004-09-13 Sulfonamide derivatives for the treatment of diabetes

Publications (1)

Publication Number Publication Date
ATE551997T1 true ATE551997T1 (de) 2012-04-15

Family

ID=34306923

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787131T ATE551997T1 (de) 2003-09-12 2004-09-13 Sulfonamid-derivate zur behandlung von diabetes

Country Status (10)

Country Link
US (1) US7705052B2 (de)
EP (1) EP1663193B1 (de)
JP (1) JP4870562B2 (de)
AT (1) ATE551997T1 (de)
AU (1) AU2004271741A1 (de)
CA (1) CA2534312A1 (de)
ES (1) ES2385219T3 (de)
IL (1) IL174251A0 (de)
NO (1) NO20061598L (de)
WO (1) WO2005025558A1 (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1409483B1 (de) * 2001-07-23 2008-12-31 Laboratoires Serono SA Arylsulfonamidderivate als hemmer c-jun-terminaler kinasen (jnk)
JP4870562B2 (ja) 2003-09-12 2012-02-08 メルク セローノ ソシエテ アノニム 糖尿病の治療のためのスルホンアミド誘導体
AU2011265521B9 (en) * 2005-07-15 2014-05-22 Merck Serono Sa JNK inhibitors for the treatment of endometreosis
CN101258144B (zh) * 2005-08-12 2012-05-30 苏文生命科学有限公司 作为功能性5-ht6配体的氨基芳基磺酰胺衍生物
JP5301465B2 (ja) * 2007-01-25 2013-09-25 バーバ・ファーマシューティカルズ・リミテッド インスリン抵抗性改善薬および治療方法
US8225729B2 (en) * 2008-12-16 2012-07-24 Kimberly-Clark Worldwide, Inc. Three-dimensional wiping substrate and method therefor
US8882735B2 (en) * 2008-12-16 2014-11-11 Kimberly-Clark Worldwide, Inc. Article with fluid-activated barriers
US8507746B2 (en) * 2008-12-16 2013-08-13 Kimberly-Clark Worldwide, Inc. Leakage-signaling absorbent article
US7858055B2 (en) * 2008-12-18 2010-12-28 Kimberly-Clark Worldwide, Inc. Moisture sensitive auxetic material
WO2010084160A1 (en) 2009-01-21 2010-07-29 Oryzon Genomics S.A. Phenylcyclopropylamine derivatives and their medical use
CN102639496B (zh) 2009-09-25 2014-10-29 奥瑞泽恩基因组学股份有限公司 赖氨酸特异性脱甲基酶-1抑制剂及其应用
US8946296B2 (en) 2009-10-09 2015-02-03 Oryzon Genomics S.A. Substituted heteroaryl- and aryl-cyclopropylamine acetamides and their use
WO2011106573A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
WO2011106574A2 (en) 2010-02-24 2011-09-01 Oryzon Genomics, S.A. Inhibitors for antiviral use
JP5868948B2 (ja) 2010-04-19 2016-02-24 オリゾン・ジェノミックス・ソシエダッド・アノニマＯｒｙｚｏｎ Ｇｅｎｏｍｉｃｓ Ｓ．Ａ． リジン特異的脱メチル化酵素１阻害薬およびその使用
EP2575815A4 (de) * 2010-06-04 2013-12-25 Albany Molecular Res Inc Glycin-transporter-1-hemmer, verfahren zu ihrer herstellung und ihre verwendung
US9006449B2 (en) 2010-07-29 2015-04-14 Oryzon Genomics, S.A. Cyclopropylamine derivatives useful as LSD1 inhibitors
RU2611437C2 (ru) 2010-07-29 2017-02-22 Оризон Дженомикс С.А. Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
CA2808590A1 (en) * 2010-08-23 2012-03-01 Amgen Inc. Sulfonylpiperazine derivatives that interact with glucokinase regulatory protein for the treatment of diabetes
WO2012045883A1 (en) 2010-10-08 2012-04-12 Oryzon Genomics S.A. Cyclopropylamine inhibitors of oxidases
WO2012072713A2 (en) 2010-11-30 2012-06-07 Oryzon Genomics, S.A. Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
US8708988B2 (en) 2010-12-03 2014-04-29 Kimberly-Clark Worldwide, Inc. Absorbent article configured for controlled deformation
EP3981395A1 (de) 2011-02-08 2022-04-13 Oryzon Genomics, S.A. Lysindemethylase-hemmer für myeloproliferative erkrankungen
CN103958474B (zh) 2011-10-20 2017-03-08 奥莱松基因组股份有限公司 作为lsd1抑制剂的(杂)芳基环丙基胺化合物
AU2012324803B9 (en) 2011-10-20 2017-08-24 Oryzon Genomics, S.A. (hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
CN105188692A (zh) * 2013-03-29 2015-12-23 国立大学法人熊本大学 2型糖尿病治疗剂
WO2015123408A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
WO2015123437A1 (en) 2014-02-13 2015-08-20 Incyte Corporation Cyclopropylamines as lsd1 inhibitors
AU2015217073B2 (en) 2014-02-13 2019-08-22 Incyte Holdings Corporation Cyclopropylamines as LSD1 inhibitors
SI3105226T1 (sl) 2014-02-13 2019-11-29 Incyte Corp Ciklopropilamini kot zaviralci LSD1
US9695168B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors
TW201613925A (en) 2014-07-10 2016-04-16 Incyte Corp Imidazopyrazines as LSD1 inhibitors
US9695167B2 (en) 2014-07-10 2017-07-04 Incyte Corporation Substituted triazolo[1,5-a]pyridines and triazolo[1,5-a]pyrazines as LSD1 inhibitors
US9758523B2 (en) 2014-07-10 2017-09-12 Incyte Corporation Triazolopyridines and triazolopyrazines as LSD1 inhibitors
EA039196B1 (ru) * 2014-10-08 2021-12-16 Инсайт Корпорейшн Циклопропиламины в качестве ингибиторов lsd1
AU2016243939B2 (en) 2015-04-03 2020-09-03 Incyte Holdings Corporation Heterocyclic compounds as LSD1 inhibitors
CN110402244B (zh) 2015-08-12 2023-02-03 因赛特公司 Lsd1抑制剂的盐
EP3445339B1 (de) 2016-04-22 2023-08-23 Incyte Corporation Formulierungen eines lsd1-inhibitors
WO2020047198A1 (en) 2018-08-31 2020-03-05 Incyte Corporation Salts of an lsd1 inhibitor and processes for preparing the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3174901A (en) * 1963-01-31 1965-03-23 Jan Marcel Didier Aron Samuel Process for the oral treatment of diabetes
US3454635A (en) * 1965-07-27 1969-07-08 Hoechst Ag Benzenesulfonyl-ureas and process for their manufacture
US4927831A (en) 1988-10-20 1990-05-22 American Home Products Spiro-isoquinoline-pyrrolidine tetrones and analogs thereof useful as aldose reductase inhibitors
CN1332943C (zh) 1998-07-08 2007-08-22 萨诺费－阿文蒂斯德国有限公司 硫取代的磺酰基氨基羧酸n－芳基酰胺,其制备方法、用途以及含有该化合物的药物制剂
EP1088815A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmaceutisch Aktive Sulfonyl-Aminosäurederivate
EP1088821A1 (de) * 1999-09-28 2001-04-04 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksamer Sulfonamid Derivate
EP1193256A1 (de) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch aktive Benzolsulfonamidderivate als JNK-Proteininhibitoren
EP1193267A1 (de) 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch wirksame hydrophile Sulfonamidderivate zur Verwendung als Proteinjunkinasehemmer
EP1193268A1 (de) * 2000-09-27 2002-04-03 Applied Research Systems ARS Holding N.V. Pharmazeutisch aktive Sulfonamidderivate mit sowohl lipophilen als auch ionisierbaren Gruppen als Inhibitoren von Protein-JunKinasen
WO2002100396A1 (en) 2001-06-07 2002-12-19 Wyeth COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT
EP1409483B1 (de) * 2001-07-23 2008-12-31 Laboratoires Serono SA Arylsulfonamidderivate als hemmer c-jun-terminaler kinasen (jnk)
JP4870562B2 (ja) 2003-09-12 2012-02-08 メルク セローノ ソシエテ アノニム 糖尿病の治療のためのスルホンアミド誘導体

Also Published As

Publication number Publication date
EP1663193B1 (de) 2012-04-04
ES2385219T3 (es) 2012-07-19
EP1663193A1 (de) 2006-06-07
JP2007505088A (ja) 2007-03-08
WO2005025558A1 (en) 2005-03-24
CA2534312A1 (en) 2005-03-24
US20070043027A1 (en) 2007-02-22
JP4870562B2 (ja) 2012-02-08
US7705052B2 (en) 2010-04-27
IL174251A0 (en) 2006-08-01
NO20061598L (no) 2006-06-09
AU2004271741A1 (en) 2005-03-24

Similar Documents

Publication Publication Date Title
ATE551997T1 (de) Sulfonamid-derivate zur behandlung von diabetes
ES2572155T3 (es) Compuestos insecticidas
EA200870470A1 (ru) Ингибиторы 11-бета-гидроксистероид дегидрогеназы 1
EA200600527A1 (ru) Активирующее ppar соединение и содержащая его фармацевтическая композиция
RS51693B (en) PROCESS FOR OBTAINING OXYCODONE HYDROCHLORIDE WITH LESS THAN 25 ppm 14-HYDROXYCODEINONE
PE20070136A1 (es) COMPUESTOS DERIVADOS DE N-(PIRIDIN-2-IL)-SULFONAMIDA COMO INHIBIDORES DE LA ENZIMA 11-beta-HIDROXIESTEROIDE DESHIDROGENASA HUMANA TIPO 1
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
NO20083480L (no) Piperidinoylpyrrolidiner som melanokortin type 4 reseptor agonister
NO20061614L (no) Benzimidazolacetonitriler
ATE472531T1 (de) Sulfonylverbindungen als hemmer von 11-beta- hydroxysteroiddehydrogenase-1
AR066107A1 (es) Derivados de triazolopiridin - carboxamidas y triazolopirimidin-carboxamidas, su preparacion y su aplicacion en terapeutica como inhibidores de la enzimamonoacil glicerol lipasa y composiciones qu los contienen.
WO2008155668A3 (en) Heteroarylamide pyrimidone compounds
MX2010008361A (es) Derivados de arilamida oxazepinopirimidona sustituidos.
MX2009012377A (es) Compuestos de arilamida pirimidona.
WO2008155669A3 (en) Arylamide pyrimidone derivatives for the treatment of neurodegenerative diseases
ATE455772T1 (de) Alkinylarylcarbonsäureamide
CY1108804T1 (el) Μεθοδος παρασκευης της 4β-αμινο-4'-δεμεθυλ-4- δεσοξυποδοφυλλοτοξινης.
CY1113042T1 (el) Αντιμετωπιση μυϊασης
DE602004024170D1 (de) Pyrrolidin-derivate als oxytocin antagonisten
AR068442A1 (es) Inhibidores de la epoxido hidrolasa soluble
MX2007005617A (es) Derivados de vinilaminopirazol como pesticidas.
TH98281A (th) สารประกอบไซคลิกหลอม
TH85267B (th) ซับสทิทิวเทดคาร์บอกซิลิคแอซิด
BR0316148A (pt) Pirazolinocarboxanilidas substituìdas como composições praguicidas
TH85267A (th) ซับสทิทิวเทดคาร์บอกซิลิคแอซิด